References
- Ramajayam R, Giridhar R, Yadav MR. Synthesis of novel substituted diaryl-1,4-diazepines, Khim Geterotsikl Soedin 2006; 1042.
- Yadav MR, Shirude ST, Parmar A, Balaraman R, Giridhar R. Synthesis and anti-inflammatory activity of 2,3-diaryl-4(3H)-quinazolinones, Khim Geterotsikl Soedin 2006; 1198.
- Ramajayam R, Giridhar R, Yadav MR, de Clercq E. Identification of novel non-nucleoside reverse transcriptase inhibitors using fragment-based lead generation. Med Chem Res. (In press).
- Almansa C, de Arriba AF, Cavalcanti FL, Gomez LA, Miralles A, Merlos M, Rafanell JG, Forn J. Synthesis and SAR of a new series of COX-2-selective inhibitors: Pyrazolo[1,5-a]pyrimidines. J Med Chem 2001; 44: 350
- Asproni B, Talani G, Busonero F, Pau A, Sanna S, Cerri R, Mascia MP, Sanna E, Biggio G. Synthesis, structure-activity relationships at the GABAA receptor in rat brain, and differential electrophysiological profile at the recombinant human GABAA receptor of a series of substituted 1,2-diphenylimidazoles. J Med Chem 2005; 48: 2638
- von Rauch M, Busch S, Gust R. Investigations on the effects of basic side chains on the hormonal profile of (4R,5S)/(4S,5R)-4,5-Bis(4-hydroxyphenyl)-2-imidazolines. J Med Chem 2005; 48: 466
- Goblyos A, de Vries H, Brussee J, IJzerman AP. Synthesis and biological evaluation of a new series of 2,3,5-substituted [1,2,4]-thiadiazoles as modulators of adenosine A1 receptors and their molecular mechanism of action. J Med Chem 2005; 48: 1145
- Gill AL, Frederickson M, Cleasby A, Woodhead SJ, Carr MG, Woodhead AJ, Walker MT, Congreve MS, Devine LA, Tisi D, Reilly MO, Seavers LCA, Davis DJ, Curry J, Anthony R, Padova A, Murray CW, Carr RAE, Jhoti H. Identification of novel p38 MAP kinase inhibitors using fragment-based lead generation. J Med Chem 2005; 48: 414
- Lange JHM, Coolen HKAC, van Stuivenberg HH, Dijksman JAR, Herremans AHJ, Ronken E, Keizer HG, Tipker K, McCreary AC, Veerman W, Wals HC, Stork B, Verveer PC, den Hartog AP, de Jong NMJ, Adolfs TJP, Hoogendoorn J, Kruse CG. Synthesis, biological properties, and molecular modeling investigations of novel 3,4-diarylpyrazolines as potent and selective CB1 cannabinoid receptor antagonists. J Med Chem 2004; 47: 627
- Tron GC, Pagliai F, Grosso ED, Genazzani AA, Sorba G. Synthesis and cytotoxic evaluation of combretafurazans. J Med Chem 2005; 48: 3260
- Meanwell NA, Rosenfeld MJ, Kim Wright JJ, Brassard CL, Buchanan J0, Federici ME, Fleming JS, Gamberdella M, Hartl KS, Zavoico GB, Seiler SM. Nonprostanoid prostacyclin mimetics. 4. Derivatives of 2-[3-[2-(4,5-diphenyl-2-oxazolyl)ethyl]phenoxy]acetic acid substituted.alpha. to the oxazole ring. J Med Chem 1993; 36: 3871
- Guillemont J, Pasquier E, Palandjian P, Vernier D, Gaurrand S, Lewi PJ, Heeres J, de Jonge MR, Koymans LMH, Daeyaert FFD, Vinkers MH, Arnold E, Das K, Pauwels R, Andries K, de Bethune MP, Bettens E, Hertogs K, Wigerinck P, Timmerman P, Janssen PAJ. Synthesis of novel diarylpyrimidine analogues and their antiviral activity against human immunodeficiency virus type 1. J Med Chem 2005; 48: 2072
- Nawrocka W, Sztuba B, Opolski A, Wietrzyk J, Kowalska MW, Glowiak T. Synthesis and antiproliferative activity in vitro of novel 1,5-benzodiazepines, Part II. Arch Pharm Pharm Med Chem 2001; 334: 3, and references cited therein.
- Thakar KA, Muley PR. Indian J Chem 1975; 14: 226
- O'Brien J, Wilson I, Orton T, Pognan F. Investigation of the alamar blue (resazurin) fluorescent dye for the assessment of mammalian cell cytotoxicity. Eur J Biochem 2000; 267: 5421
- Borkhade KT, Marathey MG. Indian J Chem 1970; 8: 796
- Lloyd D, McDougall RH, Marshall DR. Part V- 2,3-Dihydro-1H-1,4-diazepines. J Chem Soc 1966; 4: 780
- Ghosh C, Tewari NJ. Heterocyclic systems. 8. condensation reactions of 4-oxo-4H-[1]benzopyran-3-carbonitrile. J Org Chem 1980; 45: 1964